TC
Truvestments Capital Portfolio holdings
AUM $500M
1-Year Return
21.66%
This Quarter Return
+5.04%
1 Year Return
+21.66%
3 Year Return
+70.79%
5 Year Return
+126.92%
10 Year Return
–
AUM
$188M
AUM Growth
+$10.4M
(+5.9%)
Cap. Flow
+$4.63M
Cap. Flow
% of AUM
2.47%
Top 10 Holdings %
Top 10 Hldgs %
18.44%
Holding
976
New
54
Increased
191
Reduced
228
Closed
305
Top Buys
| 1 |
Ryder
R
|
+$477K |
| 2 |
Coterra Energy
CTRA
|
+$455K |
| 3 |
Verizon
VZ
|
+$448K |
| 4 |
CareTrust REIT
CTRE
|
+$437K |
| 5 |
Sonoco
SON
|
+$435K |
Top Sells
| 1 |
Amazon
AMZN
|
+$486K |
| 2 |
Ingredion
INGR
|
+$447K |
| 3 |
IBM
IBM
|
+$415K |
| 4 |
Oneok
OKE
|
+$380K |
| 5 |
Essential Properties Realty Trust
EPRT
|
+$379K |
Sector Composition
| 1 | Technology | 23.71% |
| 2 | Real Estate | 19.27% |
| 3 | Industrials | 13.55% |
| 4 | Healthcare | 8.87% |
| 5 | Consumer Discretionary | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Vanguard FTSE All-World ex-US ETF
VEU
$50.6B
| $5.35K | ﹤0.01% |
100
| – | – |
|
502
INNOVATE Corp
VATE
$63.3M
| $5.35K | ﹤0.01% |
+180
| New | +$5.35K |
|
503
Dyne Therapeutics
DYN
$1.83B
| $5.35K | ﹤0.01% |
+464
| New | +$5.35K |
|
504
Doximity
DOCS
$13.6B
| $5.34K | ﹤0.01% |
165
-319
| -66% | -$10.3K |
|
505
Lincoln National
LNC
$7.82B
| $5.33K | ﹤0.01% |
237
+123
| +108% | +$2.76K |
|
506
Savara
SVRA
$624M
| $5.29K | ﹤0.01% |
+2,713
| New | +$5.29K |
|
507
Prothena Corp
PRTA
$439M
| $5.24K | ﹤0.01% |
+108
| New | +$5.24K |
|
508
Thermo Fisher Scientific
TMO
$179B
| $5.19K | ﹤0.01% |
+9
| New | +$5.19K |
|
509
AerSale
ASLE
$407M
| $5.17K | ﹤0.01% |
300
-91
| -23% | -$1.57K |
|
510
Knowles
KN
$1.91B
| $5.1K | ﹤0.01% |
300
| – | – |
|
511
GE HealthCare
GEHC
$35.5B
| $5.09K | ﹤0.01% |
+62
| New | +$5.09K |
|
512
Vanguard Global ex-US Real Estate ETF
VNQI
$3.56B
| $4.95K | ﹤0.01% |
+122
| New | +$4.95K |
|
|
VSTO
513
DELISTED
Vista Outdoor Inc.
VSTO
| $4.93K | ﹤0.01% |
178
| – | – |
|
514
Pliant Therapeutics
PLRX
$93.9M
| $4.89K | ﹤0.01% |
+184
| New | +$4.89K |
|
515
Kymera Therapeutics
KYMR
$3.38B
| $4.83K | ﹤0.01% |
163
+104
| +176% | +$3.08K |
|
|
ITCI
516
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.82K | ﹤0.01% |
89
| – | – |
|
517
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $4.81K | ﹤0.01% |
+447
| New | +$4.81K |
|
518
Endava
DAVA
$513M
| $4.77K | ﹤0.01% |
71
-140
| -66% | -$9.41K |
|
519
Strive US Energy ETF
DRLL
$264M
| $4.73K | ﹤0.01% |
170
| – | – |
|
520
DexCom
DXCM
$29.6B
| $4.65K | ﹤0.01% |
+40
| New | +$4.65K |
|
521
Syndax Pharmaceuticals
SNDX
$1.36B
| $4.6K | ﹤0.01% |
+218
| New | +$4.6K |
|
522
Olema Pharmaceuticals
OLMA
$549M
| $4.59K | ﹤0.01% |
+1,323
| New | +$4.59K |
|
523
CareDx
CDNA
$746M
| $4.53K | ﹤0.01% |
496
+242
| +95% | +$2.21K |
|
524
iShares Semiconductor ETF
SOXX
$14.3B
| $4.45K | ﹤0.01% |
30
| – | – |
|
525
Howmet Aerospace
HWM
$75.6B
| $4.24K | ﹤0.01% |
100
| – | – |
|